Suppression of fatty acid synthase, differentiation and lipid accumulation in adipocytes by curcumin
- 778 Downloads
Curcumin is a well-known component of the cook seasoning and traditional herb turmeric (Curcuma longa), which has been reported to prevent obesity. However, the mechanism still remains to be determined. In this study, curcumin is found to be an effective inhibitor of fatty acid synthase (FAS), and its effects on adipocytes are further evaluated. Curcumin shows both fast-binding and slow-binding inhibitions to FAS. Curcumin inhibits FAS with an IC50 value of 26.8 μM, noncompetitively with respect to NADPH, and partially competitively against both substrates acetyl-CoA and malonyl-CoA. This suggests that the malonyl/acetyl transferase domain of FAS possibly is the main target of curcumin. The time-dependent inactivation shows that curcumin inactivates FAS with two-step irreversible inhibition, a specific reversible binding followed by an irreversible modification by curcumin. Like other classic FAS inhibitors, curcumin prevents the differentiation of 3T3–L1 cells, and thus represses lipid accumulation. In the meantime, curcumin decreases the expression of FAS, down-regulates the mRNA level of PPARγ and CD36 during adipocyte differentiation. Curcumin is reported here as a novel FAS inhibitor, and it suppresses adipocyte differentiation and lipid accumulation, which is associated with its inhibition of FAS. Hence, curcumin is considered to be having potential application in the prevention of obesity.
KeywordsCurcumin Fatty acid synthase Inhibitor Lipid accumulation Adipocyte differentiation
This study was supported by Grants from the National Natural Science Foundation of China No. 30670455 and No. 30572252.
- 3.Kim EK, Miller I, Landree LE, Borisy-Rudin FF, Brown P, Tihan T, Townsend CA, Witters LA, Moran TH, Kuhajda FP, Ronnett GV (2002) Expression of fas within hypothalamic neurons: a model for decreased food intake after c75 treatment. Am J Physiol 283(5):E867–E879Google Scholar
- 5.Hu Z, Cha SH, Chohnan S, Lane MD (2003) Hypothalamic malonyl-coa as a mediator of feeding behavior. Proceedings of the National Academy of Sciences of the United States of America 100(22):12624–12629Google Scholar
- 12.Tian WX, Hsu RY, Wang YS (1985) Studies on the reactivity of the essential sulfhydryl groups as a conformational probe for the fatty acid synthetase of chicken liver. Inactivation by 5, 5′-dithiobis-(2-nitrobenzoic acid) and intersubunit cross-linking of the inactivated enzyme. J Biol Chem 260(20):11375–11387PubMedGoogle Scholar
- 14.Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R (2004) Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: role of exogenous dietary fatty acids, p53–p21waf1/cip1, erk1/2 mapk, p27kip1, brca1, and nf-kappab. Int J Oncol 24(3):591–608PubMedGoogle Scholar
- 18.Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V, Yeldandi AV, Rao MS, Gonzalez FJ, Reddy JK (2003) Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (ppargamma1) overexpression. J Biol Chem 278(1):498–505PubMedCrossRefGoogle Scholar
- 26.Tzameli I, Fang H, Ollero M, Shi H, Hamm JK, Kievit P, Hollenberg AN, Flier JS (2004) Regulated production of a peroxisome proliferator-activated receptor-gamma ligand during an early phase of adipocyte differentiation in 3t3–l1 adipocytes. J Biol Chem 279(34):36093–36102PubMedCrossRefGoogle Scholar